These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 974036)

  • 21. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.
    Moayedi B; Gharagozloo M; Esmaeil N; Maracy MR; Hoorfar H; Jalaeikar M
    Eur J Haematol; 2013 Mar; 90(3):202-9. PubMed ID: 23278124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts in the overall management of thalassemia.
    Propper RD
    Ann N Y Acad Sci; 1980; 344():375-83. PubMed ID: 6930877
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake.
    Wardrop SL; Richardson DR
    Eur J Biochem; 1999 Jul; 263(1):41-9. PubMed ID: 10429185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A direct method for quantification of non-transferrin-bound iron.
    Singh S; Hider RC; Porter JB
    Anal Biochem; 1990 May; 186(2):320-3. PubMed ID: 2363505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1.
    al-Refaie FN; Wickens DG; Wonke B; Kontoghiorghes GJ; Hoffbrand AV
    Br J Haematol; 1992 Oct; 82(2):431-6. PubMed ID: 1419825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth of human tumor cell lines in transferrin-free, low-iron medium.
    Neumannova V; Richardson DR; Kriegerbeckova K; Kovar J
    In Vitro Cell Dev Biol Anim; 1995 Sep; 31(8):625-32. PubMed ID: 8528518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of iron transfer from rabbit transferrin to reticulocytes using synthetic chelating agents.
    Morgan EH
    Biochim Biophys Acta; 1971 Jul; 244(1):103-16. PubMed ID: 5000975
    [No Abstract]   [Full Text] [Related]  

  • 29. [Non-transferrin-bound iron in 4 patients with excessive amounts of iron in the blood].
    Vernet-Nyssen M; Abramian S; Girard D; Bel A
    Nouv Presse Med; 1982 Dec; 11(50):3725-6. PubMed ID: 7170173
    [No Abstract]   [Full Text] [Related]  

  • 30. [CHELATING TREATMENT OF HEMOCHROMATOSIS WITH DESFERRIOXAMINE BY MOUTH AND PARENTERAL ADMINISTRATION].
    ANGELINO PF; FERRO GF; VACCA G; MEDICI L
    Minerva Med; 1964 Jan; 55():75-7. PubMed ID: 14128430
    [No Abstract]   [Full Text] [Related]  

  • 31. Non-transferrin-bound iron in long-term transfusion in children with congenital anemias.
    Wang WC; Ahmed N; Hanna M
    J Pediatr; 1986 Apr; 108(4):552-7. PubMed ID: 3083076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compliance with therapy in Cooley's anaemia.
    Vullo C; Di Palma A
    Prog Clin Biol Res; 1989; 309():43-9. PubMed ID: 2780749
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathogenesis and management of iron toxicity in thalassemia.
    Hershko C
    Ann N Y Acad Sci; 2010 Aug; 1202():1-9. PubMed ID: 20712765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Iron overload in a beta thalassemia heterozygote of the intermediate type in a subject of Alsation origin. Results of iron chelation treatment].
    North ML; Lang JM; Bergerat JP; Giron C; Oberling F; Mayer S
    Nouv Rev Fr Hematol (1978); 1984; 26(5):317-21. PubMed ID: 6334273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron mobilization from cultured hepatocytes: effect of desferrioxamine B.
    Octave JN; Schneider YJ; Crichton RR; Trouet A
    Biochem Pharmacol; 1983 Nov; 32(22):3413-8. PubMed ID: 6651865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of iron overload.
    Hershko C; Link G; Cabantchik I
    Ann N Y Acad Sci; 1998 Jun; 850():191-201. PubMed ID: 9668540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron release from transferrin: synergistic interaction between adenosine triphosphate and an ammonium sulfate fraction of hemolysate.
    Pollack S; Weaver J
    J Lab Clin Med; 1986 Nov; 108(5):411-4. PubMed ID: 3772222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonspecific serum iron in thalassemia: quantitation and chemical reactivity.
    Graham G; Bates GW; Rachmilewitz EA; Hershko C
    Am J Hematol; 1979; 6(3):207-17. PubMed ID: 484544
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-transferrin-bound iron and tumor cells.
    Anghileri LJ; Thouvenot P
    Anticancer Res; 1997; 17(4A):2529-33. PubMed ID: 9252675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [PRELIMINARY NOTE ON THE THERAPEUTIC USE OF DESFERRIOXAMINE IN COOLEY'S DISEASE].
    ROMANO C; MASSIMO L; TORTOROLO G
    Minerva Pediatr; 1964 Jun; 16():711-3. PubMed ID: 14180248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.